MapLight Therapeutics, Inc.
Pharmaceutical company · Redwood City, California, United States · Nasdaq: MPLT
MapLight Therapeutics, Inc. is a pharmaceutical company headquartered in Redwood City, California, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker MPLT. It has reported private securities offerings to the US SEC, most recently $188 million sold in a notice filed in 2025.
MapLight Therapeutics at a glance
What does MapLight Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $188.2 million sold (2025).
Frequently asked questions about MapLight Therapeutics
Where is MapLight Therapeutics headquartered?
MapLight Therapeutics, Inc. is headquartered in Redwood City, California, United States.
What does MapLight Therapeutics do?
MapLight Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is MapLight Therapeutics a public company?
Yes. MapLight Therapeutics, Inc. trades on Nasdaq under the ticker MPLT.
When was MapLight Therapeutics founded?
The earliest incorporation on record for MapLight Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Soleno Therapeutics IncRedwood City, California, United States
- Xenoport IncRedwood City, California, United States
- Bolt Biotherapeutics, Inc.Redwood City, California, United States
- Corcept Therapeutics IncRedwood City, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.